14 July 2025NewsAmericasEva Ehlich, Maiwald | Lisa Flanagan, Regeneron | Christina Rodrigo, Vertex Pharmaceuticals | Manja Epping, Taylor Wessing
WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of increased transparency requirements in clinical trials and their effects on the global patent system. The session focuses on recent regulatory changes, especially in Europe, and the challenges they present for IP protection.
